Time to rethink vascular access in patients with breast cancer.

British Journal of Nursing : BJN
Sheryl McDiarmid, Gail Larocque

Abstract

Breast cancer management is a rapidly evolving field. Diagnosis and treatment options have changed dramatically over the years, as have options for vascular access devices used to administer therapies. We now need to critically rethink vascular access device options for our breast cancer patients. Breast cancer (BC) is the most commonly diagnosed cancer among Canadian women. Although BC incidence continues to rise, the overall mortality rate in Canada is the lowest it has been for 70 years. The five-year net survival is 87%, and 83% of women are alive at 10 years. New oral therapies, shorter dose-dense treatments, and decreased use of anthracycline-base regimens are reducing the need for central venous access devices during acute treatment phases. However, these survivors go on to develop other health issues requiring routine venipuncture and insertion of vascular access devices. Breast cancer-related lymphedema (BCRL) is a chronic complication that has no cure and no proven prevention strategies. Approximately 21% of breast cancer survivors are at risk of developing BCRL. Of those patients who do develop BCRL, 70% do so within two years of surgery, 90% within three years, and another one percent per year thereafter. The litera...Continue Reading

References

Feb 1, 1992·American Journal of Physical Medicine & Rehabilitation·M J Brennan, J Weitz
Jun 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A E GiulianoR Statman
May 3, 2001·Journal of the National Cancer Institute·J S Abrams
Jan 16, 2002·Breast Cancer : the Journal of the Japanese Breast Cancer Society·J S Abrams
Aug 7, 2003·Journal of Vascular and Interventional Radiology : JVIR·Ripal T GandhiNeil Khilnani
Apr 12, 2005·QJM : Monthly Journal of the Association of Physicians·B ClarkW Harlow
Mar 24, 2007·International Journal of Radiation Oncology, Biology, Physics·Gary M FreedmanMonica Morrow
May 9, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anthony LucciUNKNOWN American College of Surgeons Oncology Group
Aug 2, 2011·Journal of the American College of Surgeons·Yeliz CemalBabak J Mehrara
Mar 13, 2012·Lymphatic Research and Biology·Beth NewmanSandra C Hayes
Oct 12, 2012·Annals of Surgical Oncology·Shayna L ShowalterKathryn H Schmitz
Dec 26, 2012·Journal of the American College of Surgeons·Sarah A McLaughlinJustin Nguyen
Nov 28, 2013·ANZ Journal of Surgery·Chris-Tin ChengSharon L Kilbreath
Dec 17, 2014·The New England Journal of Medicine·Prudence A FrancisUNKNOWN International Breast Cancer Study Group
Dec 9, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chantal M FergusonAlphonse G Taghian
Dec 30, 2015·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Mary Alexander
Feb 3, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Elizabeth S McDonaldGary M Freedman
May 18, 2016·The Breast : Official Journal of the European Society of Mastology·S L KilbreathK Gaitatzis
Nov 11, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F CardosoK A Gelmon
Jun 5, 2018·The New England Journal of Medicine·Joseph A SparanoGeorge W Sledge
Jun 5, 2018·The New England Journal of Medicine·Prudence A FrancisUNKNOWN SOFT and TEXT Investigators and the International Breast Cancer Study Group

❮ Previous
Next ❯

Citations

May 28, 2021·Anesthesia and Analgesia·Julian NaranjoGregory A Nuttall

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
dissection
blood draws

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved